Kisspeptin-10 Made in USA — Third-Party Verified
Kisspeptin-10 is a critical decapeptide studied extensively for its role in the upstream regulation of the reproductive hormone axis. PX1 Research provides USA-synthesized Kisspeptin-10 manufactured under stringent quality controls, offering verified mass spectrometry, HPLC purity analytics, and low endotoxin levels for demanding in vitro and preclinical research applications.
Quick answer
Kisspeptin-10 is a critical decapeptide studied extensively for its role in the upstream regulation of the reproductive hormone axis. PX1 Research provides USA-synthesized Kisspeptin-10 manufactured under stringent quality controls, offering verified mass spectrometry, HPLC purity analytics, and low endotoxin levels for demanding in vitro and preclinical research applications.
Key takeaways
- [Kisspeptin](/research-peptides/kisspeptin-10)-10 is a naturally occurring 10-amino-acid peptide derived from the cleavage of the KISS1 gene precursor product.
- The primary sequence of [Kisspeptin](/research-peptides/kisspeptin-10)-10 comprises the C-terminal sequence of the longer Kisspeptin-54 precursor (specifically YNWNSFGLRF-NH2 with C-terminal amidation).
- The hypothalamic-pituitary-gonadal axis serves as the primary endocrine network controlling reproductive function.
- When evaluating peptidergic tools within neuroendocrinology, researchers often compare upstream regulators like [Kisspeptin](/research-peptides/kisspeptin-10)-10 against direct pituitary secretagogues.
Introduction to Kisspeptin-10 in Preclinical Research
Kisspeptin-10 is a naturally occurring 10-amino-acid peptide derived from the cleavage of the KISS1 gene precursor product. Recognized primary as a master reproductive signaling peptide, it plays a foundational role in initiating and regulating the hypothalamic-pituitary-gonadal (HPG) axis. Researchers evaluating endocrine cascades, neuroendocrine pulsatility, and reproductive physiology utilize high-purity Kisspeptin-10 to map signal transduction within central hypothalamic networks.
In mammalian models, the peptide acts upstream of classical gonadotropin-releasing hormone (GnRH) pathways. By binding selectively to the G protein-coupled receptor KISS1R (formerly known as GPR54), Kisspeptin-10 stimulates the downstream release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Investigating this mechanism allows scientists to analyze neuroendocrine feedback loops without relying on downstream peripheral hormones, making it an essential tool across molecular endocrinology and developmental biology research.
Molecular Architecture and Receptor Binding Kinetics
The primary sequence of Kisspeptin-10 comprises the C-terminal sequence of the longer Kisspeptin-54 precursor (specifically YNWNSFGLRF-NH2 with C-terminal amidation). This truncated sequence represents the minimal active core required for full biological activity at the KISS1R locus. The presence of the carboxyl-terminal amide group is essential for maintaining peptide stability against rapid enzymatic degradation and ensuring high-affinity binding to its cognate receptor.
In vitro radioligand binding assays demonstrate that Kisspeptin-10 exhibits nanomolar affinity for human and rodent KISS1R receptors. Upon ligand binding, KISS1R activates the Gq/11-coupled signaling pathway, triggering phospholipase C (PLC) activation, intracellular calcium mobilization, and downstream phosphorylation of extracellular signal-regulated kinases (ERK1/2). Preclinical models rely on consistent peptide molecular weight (1302.45 g/mol) and net charge characteristics to ensure reproducible receptor activation across cellular assays.
Upstream Regulation of the HPG Axis
The hypothalamic-pituitary-gonadal axis serves as the primary endocrine network controlling reproductive function. Traditional models focused heavily on GnRH as the primary driver of gonadotropin release; however, current consensus identifies Kisspeptin signaling as the crucial master switch located upstream of GnRH neurons.
In animal models, Kisspeptin-10 directly stimulates GnRH neurosecretory terminals in the median eminence. High-frequency pulse generator activity in these neurons coordinates the episodic release of LH and FSH into circulation. Researchers studying hypogonadotropic conditions or central neuroendocrine suppression utilize research peptides targeting the KISS1R receptor to assess whether pituitary responsiveness remains intact when upstream hypothalamic activation is experimentally modulated.
Comparative Analysis: Kisspeptin-10 vs. Downstream Secretagogues
When evaluating peptidergic tools within neuroendocrinology, researchers often compare upstream regulators like Kisspeptin-10 against direct pituitary secretagogues. While Kisspeptin-10 operates at the level of the hypothalamus to induce endogenous, pulsatile GnRH release, compounds such as gonadorelin act directly upon gonadotropes in the anterior pituitary gland.
Furthermore, potent synthetic analogs like triptorelin or long-acting GnRH agonists target pituitary receptors continuously, frequently leading to receptor desensitization and down-regulation. In contrast, Kisspeptin-10 preserves physiological feedback mechanisms in preclinical models, providing a distinct experimental vector for mapping homeostatic recovery and central signaling dynamics. Establishing clear comparative baselines between these classes is critical for designing precise in vitro and animal models.
Why Domestic Synthesis Matters for Research Integrity
The reproducibility of scientific research hinges on compound quality, chemical purity, and manufacturing consistency. Obtaining kisspeptin-10 made in usa ensures that laboratories receive research reagents synthesized under rigid domestic standards. Foreign-sourced peptides frequently suffer from lot-to-lot variability, uncharacterized enantiomeric impurities, residue solvents, or heavy metal contamination that can confound cell culture assays and animal studies.
PX1 Research utilizes advanced solid-phase peptide synthesis (SPPS) in GMP-compliant USA facilities. Domestic manufacturing allows for absolute oversight across every synthetic step—from amino acid coupling efficiency to final trifluoroacetic acid (TFA) clearance. For academic investigators and contract research organizations (CROs), sourcing domestically removes supply chain opacity and guarantees immediate access to rigorous analytical documentation.
Analytical Validation: HPLC, Mass Spectrometry, and Endotoxin Testing
Every lot of Kisspeptin-10 supplied by PX1 Research undergoes rigorous third-party verification prior to release. Analytical validation is performed by independent, ISO 17025 accredited laboratories using High-Performance Liquid Chromatography (HPLC) coupled with Electrospray Ionization Mass Spectrometry (ESI-MS).
HPLC testing verifies chemical purity, ensuring that every batch meets or exceeds our strict >98% purity threshold by quantifying and excluding synthesis truncations or sequence deletions. Mass spectrometry confirms exact molecular identity by verifying the theoretical monoisotopic mass. Furthermore, because bacterial lipopolysaccharides (LPS) can invalidate cell viability studies and induce systemic inflammatory responses in animal models, PX1 subjects every batch to chromogenic Limulus Amebocyte Lysate (LAL) testing to enforce strict endotoxin limits (<0.01 EU/mg).
Reconstitution Protocols and Lyophilized Stability in Laboratory Settings
Kisspeptin-10 is provided as a sterile, lyophilized cake or powder to maximize long-term chemical stability. To ensure proper dissolution and preserve peptide integrity during laboratory preparation, researchers should follow standardized reconstitution protocols.
Lyophilized vials should be allowed to equilibrate to room temperature before opening to prevent condensation from introducing moisture. Reconstitution should be performed using sterile Bacteriostatic Water, Sterile Water for Injection, or phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the planned assay. Gentle swirling or slow inversion is recommended; vigorous vortexing or mechanical shaking must be avoided to prevent protein shear stress and aggregation. Researchers utilizing specific concentration parameters can utilize our online reconstitution calculator for precise concentration modeling.
Storage, Handling, and Degradation Pathways
Lyophilized peptides remain stable when stored at -20°C or -80°C in a desiccated environment protected from light exposure. Avoid repeated freeze-thaw cycles, as temperature fluctuations promote hydrolytic cleavage and peptide aggregation over time.
Once reconstituted into aqueous solution, Kisspeptin-10 aliquots should be used immediately or stored at -80°C for short-term experimental series. Working solutions maintained at 2°C to 8°C exhibit limited stability and should be used within a controlled timeframe. Protecting peptide solutions from UV light and oxygen exposure minimizes photo-oxidation of the tryptophan (W) and phenylalanine (F) residues present within the decapeptide sequence.
Procurement and Institutional Sourcing Options
PX1 Research supports university laboratories, private biotech firms, and institutional research facilities with streamlined procurement pathways. Orders placed before cut-off times ship same-day (Monday through Friday) directly from our centralized distribution facilities in California and Arizona, ensuring rapid, reliable delivery.
For high-throughput screening, large-scale rodent studies, or long-term project planning, academic and corporate entities can access bulk procurement and customized lot-reservation programs through our wholesale lab account portal. Every shipment includes lot-specific Certificates of Analysis (COAs) downloadable directly via QR code or portal link, guaranteeing complete chain-of-custody documentation.
Frequently Asked Questions
Where is PX1 Research Kisspeptin-10 synthesized?
PX1 Research Kisspeptin-10 is 100% synthesized within the United States in GMP-compliant facilities utilizing solid-phase peptide synthesis (SPPS) protocols.
What analytical testing is conducted on Kisspeptin-10 lots?
Each batch undergoes third-party verification at an ISO 17025 accredited laboratory. Testing includes High-Performance Liquid Chromatography (HPLC) for purity determination (>98%), Electrospray Ionization Mass Spectrometry (ESI-MS) for sequence identity verification, and chromogenic LAL assays for endotoxin quantification.
What is the primary biological target of Kisspeptin-10 in preclinical research?
Kisspeptin-10 is a potent endogenous agonist at the KISS1R receptor (GPR54). It is primarily researched for its upstream regulatory role in stimulating gonadotropin-releasing hormone (GnRH) release along the hypothalamic-pituitary-gonadal (HPG) axis.
How should Kisspeptin-10 be stored upon receipt in the laboratory?
Lyophilized Kisspeptin-10 should be stored at -20°C or -80°C in a dry, dark location. Following reconstitution, liquid aliquots should be kept frozen at -80°C to minimize degradation and avoid repeated freeze-thaw cycles.
What are the recommended diluents for reconstituting Kisspeptin-10?
Depending on downstream experimental protocols, reconstituted Kisspeptin-10 can be dissolved in sterile Bacteriostatic Water, sterile saline, or sterile phosphate-buffered saline (PBS, pH 7.4). Gentle inversion without agitation is recommended.
What endotoxin levels are verified for Kisspeptin-10?
PX1 Research enforces strict endotoxin specifications, verifying that all research-grade peptide lots maintain endotoxin thresholds below 0.01 EU/mg to prevent unspecific cellular or immunological artifacts.
How does Kisspeptin-10 differ from direct GnRH agonists like gonadorelin?
Kisspeptin-10 acts upstream at the hypothalamic level to stimulate natural GnRH release, whereas direct GnRH agonists like gonadorelin or triptorelin act directly on pituitary gonadotropin receptors.
Can institutional buyers request bulk or custom manufacturing lots?
Yes, PX1 Research offers institutional pricing, custom lot reservation, and bulk synthesis for academic and private research facilities through our dedicated wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.